FDA Inspection 1252647 — Daniel Cosgrove, M.D.
The FDA completed an inspection of Daniel Cosgrove, M.D. on Oct 9, 2024 in Encino, CA. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Devices.
Inspection Details
- Classification
- No Action Indicated (NAI)
- End Date
- Oct 9, 2024
- Fiscal Year
- 2025
- Product Type
- Devices
- Project Area
- Bioresearch Monitoring
- Location
- Encino, CA (United States)
Additional Details
Clinical Investigator (CI)